Unknown

Dataset Information

0

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.


ABSTRACT: Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), is growing at an exponential rate worldwide. Manifestations of this disease are heterogeneous; however, advanced cases often exhibit various acute respiratory distress syndrome-like symptoms, systemic inflammatory reactions, coagulopathy, and organ involvements. A common theme in advanced COVID-19 is unrestrained immune activation, classically referred to as a "cytokine storm", as well as deficiencies in immune regulatory mechanisms such as T regulatory cells. While mesenchymal stem cells (MSCs) themselves are objects of cytokine regulation, they can secrete cytokines to modulate immune cells by inducing anti-inflammatory regulatory Treg cells, macrophages and neutrophils; and by reducing the activation of T and B cells, dendritic and nature killer cells. Consequently, they have therapeutic potential for treating severe cases of COVID-19. Here we discuss the unique ability of MSCs, to act as a "living anti-inflammatory", which can "rebalance" the cytokine/immune responses to restore equilibrium. We also discuss current MSC trials and present different concepts for optimization of MSC therapy in patients with COVID-19 acute respiratory distress syndrome.

SUBMITTER: Lin F 

PROVIDER: S-EPMC7596438 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.

Lin Feng F   Ichim Thomas E TE   Pingle Sandeep S   Jones Lawrence D LD   Kesari Santosh S   Ashili Shashaanka S  

World journal of stem cells 20201001 10


Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), is growing at an exponential rate worldwide. Manifestations of this disease are heterogeneous; however, advanced cases often exhibit various acute respiratory distress syndrome-like symptoms, systemic inflammatory reactions, coagulopathy, and organ involvements. A common theme in advanced COVID-19 is unrestrained immune activation, classically referred to as a "cytok  ...[more]

Similar Datasets

| S-EPMC6915956 | biostudies-literature
| S-EPMC9441842 | biostudies-literature
| S-EPMC7282699 | biostudies-literature
2023-07-13 | PXD043740 | JPOST Repository
| S-EPMC6196176 | biostudies-literature
| S-EPMC8801611 | biostudies-literature
| S-EPMC3576439 | biostudies-literature
| S-EPMC6954712 | biostudies-literature
| S-EPMC8995321 | biostudies-literature
| S-EPMC7222160 | biostudies-literature